JNJ (NYSE) - Johnson & Johnson
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US4781601046
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment provides skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. This segment also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment provides products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes, and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment offers electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and contact lenses and ophthalmic technologies related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey. Web URL:
Classification
Market Cap in USD | 391,687m |
Sector | Healthcare |
Industry | Drug Manufacturers-General |
GiC SubIndustry | Pharmaceuticals |
TER | 0.00% |
IPO / Inception | 1944-09-24 |
Ratings
Fundamental | 4.51 |
Dividend | 6.83 |
Performance 5y | 3.85 |
Rel. Performance vs Sector | 0.27 |
Analysts | 3.59 |
Fair Price Total Ret. | 148.78 |
Fair Price DCF | todo |
Technical
Growth TTM | -2.01% |
CAGR 5y | 5.17% |
CAGR / Mean Drawdown 5y | 0.85 |
Sharpe Ratio TTM | -0.44 |
Alpha vs SP500 TTM | -13.50 |
Beta vs SP500 5y weekly | 0.60 |
CAPM | 6.66% |
Average Daily Range 2m | 1.56% |
Reversal Oscillator | 16.68 |
Volatility GJR Garch 1y | 17.96% |
Price / SMA 50 | -5.24% |
Price / SMA 200 | -2.89% |
Current Volume | 10211.6k |
Average Volume 20d | 7848.2k |
Dividends
Yield TTM | 2.95% |
Yield on Cost 5y | 3.80% |
Dividends CAGR 5y | 4.68% |
Consistency of Dividends all time | 100.0% |